CRISPR-Cas9 guided rna based model for the treatment of Amyotrophic Lateral Sclerosis: A progressive neurodegenerative disorder

This study highlights the potential of CRISPR-Cas9 as a promising solution for the development of new treatments for ALS. Further research is required to validate these findings in preclinical and clinical trials and to establish the safety and efficacy of this approach in the treatment of ALS.PMID:37672770 | DOI:10.18388/abp.2020_6789

Source: Acta Biochim Pol - September 6, 2023 Category: Biochemistry Authors: Muhammad Naveed Muhammad Aqib Shabbir Tariq Aziz Hafiz Muhammad Hurraira Sayyeda Fatima Zaidi Ramsha Athar Hassan Anwer Chattha Metab Alharbi Abdulrahman Alshammari Abdullah F Alasmari Source Type: research